Stockreport

Heat Biologics Announces Promising Survival Data of HS-110 in Two Treatment Settings of Lung Cancer; Selected for Presentation at 2021 American Society of Clinical Oncology Annual Meeting

Heat Biologics, Inc.  (HTBX) 
Last heat biologics, inc. earnings: 8/14 07:00 am Check Earnings Report
PDF DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class the [Read more]